169 related articles for article (PubMed ID: 12393632)
1. DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines.
Nishihara H; Maeda M; Oda A; Tsuda M; Sawa H; Nagashima K; Tanaka S
Blood; 2002 Dec; 100(12):3968-74. PubMed ID: 12393632
[TBL] [Abstract][Full Text] [Related]
2. Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins.
Nishihara H; Kobayashi S; Hashimoto Y; Ohba F; Mochizuki N; Kurata T; Nagashima K; Matsuda M
Biochim Biophys Acta; 1999 Nov; 1452(2):179-87. PubMed ID: 10559471
[TBL] [Abstract][Full Text] [Related]
3. DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1.
Sanui T; Inayoshi A; Noda M; Iwata E; Stein JV; Sasazuki T; Fukui Y
Blood; 2003 Oct; 102(8):2948-50. PubMed ID: 12829596
[TBL] [Abstract][Full Text] [Related]
4. The CDM protein DOCK2 in lymphocyte migration.
Reif K; Cyster J
Trends Cell Biol; 2002 Aug; 12(8):368-73. PubMed ID: 12191913
[TBL] [Abstract][Full Text] [Related]
5. DOCK2 mediates T cell receptor-induced activation of Rac2 and IL-2 transcription.
Nishihara H; Maeda M; Tsuda M; Makino Y; Sawa H; Nagashima K; Tanaka S
Biochem Biophys Res Commun; 2002 Aug; 296(3):716-20. PubMed ID: 12176041
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms.
Hanawa-Suetsugu K; Kukimoto-Niino M; Mishima-Tsumagari C; Akasaka R; Ohsawa N; Sekine S; Ito T; Tochio N; Koshiba S; Kigawa T; Terada T; Shirouzu M; Nishikimi A; Uruno T; Katakai T; Kinashi T; Kohda D; Fukui Y; Yokoyama S
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3305-10. PubMed ID: 22331897
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration.
Fukui Y; Hashimoto O; Sanui T; Oono T; Koga H; Abe M; Inayoshi A; Noda M; Oike M; Shirai T; Sasazuki T
Nature; 2001 Aug; 412(6849):826-31. PubMed ID: 11518968
[TBL] [Abstract][Full Text] [Related]
8. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G.
Arai A; Nosaka Y; Kohsaka H; Miyasaka N; Miura O
Blood; 1999 Jun; 93(11):3713-22. PubMed ID: 10339478
[TBL] [Abstract][Full Text] [Related]
9. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
[TBL] [Abstract][Full Text] [Related]
11. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.
Shen Q; Rahn JJ; Zhang J; Gunasekera N; Sun X; Shaw AR; Hendzel MJ; Hoffman P; Bernier A; Hugh JC
Mol Cancer Res; 2008 Apr; 6(4):555-67. PubMed ID: 18403635
[TBL] [Abstract][Full Text] [Related]
12. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
[TBL] [Abstract][Full Text] [Related]
13. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
Antoku S; Mayer BJ
J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
[TBL] [Abstract][Full Text] [Related]
15. DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells.
Sanui T; Inayoshi A; Noda M; Iwata E; Oike M; Sasazuki T; Fukui Y
Immunity; 2003 Jul; 19(1):119-29. PubMed ID: 12871644
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.
Hasan MK; Yu J; Widhopf GF; Rassenti LZ; Chen L; Shen Z; Briggs SP; Neuberg DS; Kipps TJ
Blood; 2018 Jul; 132(2):170-178. PubMed ID: 29678828
[TBL] [Abstract][Full Text] [Related]
17. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
18. CRK proteins selectively regulate T cell migration into inflamed tissues.
Huang Y; Clarke F; Karimi M; Roy NH; Williamson EK; Okumura M; Mochizuki K; Chen EJ; Park TJ; Debes GF; Zhang Y; Curran T; Kambayashi T; Burkhardt JK
J Clin Invest; 2015 Mar; 125(3):1019-32. PubMed ID: 25621495
[TBL] [Abstract][Full Text] [Related]
19. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways.
Feller SM; Knudsen B; Hanafusa H
Oncogene; 1995 Apr; 10(8):1465-73. PubMed ID: 7731701
[TBL] [Abstract][Full Text] [Related]
20. Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of Src family kinases.
Li L; Guris DL; Okura M; Imamoto A
Mol Cell Biol; 2003 Apr; 23(8):2883-92. PubMed ID: 12665586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
